Despite this numerical difference, the comparison between the DSIP-treated and vehicle-treated MCAO groups did not yield statistical significance
Its the physiological stress of losing weight quickly
But unlike, GLP-1, it does not quickly break down, meaning it remains active in the body for an extended period, making it a perfect candidate for a diabetes drug
Starting at $1,350 OUT OF STOCK Wegovy The sister treatment to Ozempic that is specifically approved for weight loss, Wegovy is a self-injectable semaglutide FDA approved for adults with a BMI of 27 or more
Whether this translates into protection against the events that matter (kidney failure, dialysis) remains to be tested
DSIP is a 9-amino-acid peptide with a molecular weight of roughly 849 Daltons and a plasma half-life estimated at 30 to 45 minutes, which makes administration timing critical